Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

Bio-Techne Announces Commercial Release of RNAscope(TM) HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples.

PR Newswire July 27, 2021

Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results

PR Newswire July 13, 2021

Bio-techne Announces Opening Of New Ireland Facility

PR Newswire June 28, 2021

Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies

PR Newswire June 24, 2021

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021

GlobeNewswire June 15, 2021

Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities

PR Newswire June 10, 2021

Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium

PR Newswire June 8, 2021

Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order

Canada NewsWire June 2, 2021

Bio-Techne To Present At The Jefferies Virtual Healthcare Conference

PR Newswire May 19, 2021

Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications

PR Newswire May 18, 2021

Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy

PR Newswire May 10, 2021

Bio-Techne Releases Third Quarter Fiscal 2021 Results

PR Newswire May 6, 2021

Bio-Techne Declares Dividend

PR Newswire May 6, 2021

Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards

PR Newswire May 4, 2021

908 Devices and Bio-Techne Announce Joint Collaboration

Business Wire May 4, 2021

Bio-Techne Announces Commercial Release of Novel DNAscope(TM) in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

PR Newswire April 27, 2021

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

PR Newswire April 15, 2021

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

PR Newswire April 14, 2021

Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

PR Newswire April 8, 2021

Bio-Techne Completes Acquisition of Asuragen, Inc.

PR Newswire April 6, 2021